A Phase II Study of CI-1033 in Treating Patients With Metastatic (Stage IV) Breast Cancer

NCT00051051 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
168
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer